Results 1 to 10 of about 2,314,750 (241)
Türk Biyokimya DergisiPolycystic ovarian syndrome (PCOS) is a heterogeneous endocrine condition that influences 15–20 % of women at their fertile age. In this academic work, we aimed to research serum anti-mullerian hormone (AMH) levels using the Vidas® and Atellica® methods ...
Gök Gamze +5 more
doaj +3 more sources
Anti-Mullerian hormone levels in girls and adolescents [PDF]
Ginekologia Polska, 2022 Anti-Mullerian hormone (AMH) is a homodimeric glycoprotein which belongs to the TGF-beta superfamily of growth and differentiation factors. There are few studies that present AMH concentrations in premenarcheal and early postmenarcheal girls. The aim of this study is to evaluate AMH levels in girls.
Iwona J, Czech, Agnieszka, Drosdzol-Cop
openaire +4 more sources
Anti-Mullerian Hormone: Usefulness in Clinical Practice [PDF]
International Journal of Endocrinology, 2013 Anti-Mullerian hormone (AMH) is a protein that inhibits the development of the mullerian ducts (paramesonephric ducts) in the male embryo. AMH prevents the development of the mullerian ducts into the uterus and other mullerian structures in the first 8 weeks of gestational age.
Kai J. Buhling +2 more
doaj +4 more sources
Anti-Mullerian Hormone: A New Marker of Ovarian Function [PDF]
Journal of Obstetrics and Gynecology of India, 2013 The aim of this study was to determine day 3 Serum AMH, FSH, LH, Estradiol (E2), Inhibin B levels, ovarian volume, and antral follicular count to assess ovarian function.This study was conducted on 130 infertile women between age 18 and 43 years. Day 3 Serum AMH level was estimated by sandwich enzyme immunoassay; Serum FSH, S. LH, S. E2, by solid-phase
Meena, Dayal +3 more
exaly +3 more sources
Anti-Müllerian hormone versus antral follicle count as first-choice biomarkers in a low-resource setting: A cross-sectional study in Kumasi, Ghana [PDF]
Journal of International Medical ResearchObjective To evaluate age-related variations in ovarian reserve among women in Kumasi, Ghana, and determine the preferred first-choice biomarker, either anti-Müllerian hormone or antral follicle count, in a low-resource setting. Methods A cross-sectional
Francis Jojo Moses Kwadzo Damalie +7 more
doaj +2 more sources
Anti-Mullerian hormone in systemic lupus erythematosus
Современная ревматология, 2021 Currently, in patients with systemic lupus erythematosus (SLE) increasing attention is paid to the ovarian reserve evaluation, which can serve as one of the markers of a favorable response to therapy and pregnancy planning.
Z. S. Alekberova +3 more
doaj +3 more sources
Clinical Utility of Anti-Mullerian Hormone in Pediatrics [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2021 Abstract Context Anti-Mullerian hormone (AMH) was originally described in the context of sexual differentiation in the male fetus but has gained prominence now as a marker of ovarian reserve and fertility in females.
Roopa Kanakatti Shankar +3 more
openaire +2 more sources
The relationship between anti-mullerian hormone and ovarian response and fertility outcome in infertile women undergoing assisted reproductive techniques (ART) and IUI [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2023 Introduction: Anti-Mullerian Hormone (AMH) is related to woman's age, the number of antral follicles, and the outcome of assisted reproductive techniques.
Fariba Seyedoshohadaei +3 more
doaj +1 more source
Middle East Fertility Society Journal, 2021 Background Anti-Müllerian hormone is a dimeric glycoprotein produced by the granulosa cells of preantral and small antral follicles of the ovaries.
Oyinkansola Islamiyat Lawal +1 more
doaj +1 more source
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS? [PDF]
PLoS ONE, 2016 Increased Anti-Mullerian Hormone in polycystic ovary syndrome, may be due to overactive follicles rather than reflect antral follicle count.Does Anti-Mullerian Hormone reflect antral follicle count similarly in women with or without polycystic ovary ...
Sverre C Christiansen +3 more
doaj +1 more source